INFLUENCE OF ANTIARRHYTHMIC DRUGS ON THE SPECTRAL ANALYSIS OF HEART RATE VARIABILITY IN PATIENTS WITH ATRIAL FIBRILLATION
- Authors: Popova E.P.1, Bogova O.T2, Puzin S.N2, Matsokin I.S3, Gadzhimagomedova A.A2, Sychev D.A2, Fisenko V.P1
-
Affiliations:
- I.M. Sechenov First Moscow State Medical University
- Russian Medical Academy of Continuous Professional Education
- Municipal Clinical Hospital № 24
- Issue: Vol 21, No 1-2 (2018)
- Pages: 101-104
- Section: Articles
- URL: https://journal-vniispk.ru/1560-9537/article/view/36014
- DOI: https://doi.org/10.18821/1560-9537-2018-21-1-101-104
- ID: 36014
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
Ekaterina P. Popova
I.M. Sechenov First Moscow State Medical University
Email: kispo-pharm@mail.ru
MD, PhD, Associate Professor of the Department of Pharmacology, Moscow, 119435, Russian Federation Moscow, 119435, Russian Federation
O. T Bogova
Russian Medical Academy of Continuous Professional EducationMoscow, 125993, Russian Federation
S. N Puzin
Russian Medical Academy of Continuous Professional EducationMoscow, 125993, Russian Federation
I. S Matsokin
Municipal Clinical Hospital № 24Moscow, 127015, Russian Federation
A. A Gadzhimagomedova
Russian Medical Academy of Continuous Professional EducationMoscow, 125993, Russian Federation
D. A Sychev
Russian Medical Academy of Continuous Professional EducationMoscow, 125993, Russian Federation
V. P Fisenko
I.M. Sechenov First Moscow State Medical UniversityMoscow, 119435, Russian Federation
References
- Баевский Р.М., Кириллов О.И., Клецкин С.З. Математический анализ изменений сердечного ритма при стрессе. М.: Наука; 1984.
- Кринский В.И., Михайлов А.С. Автоволны. М.; Знание; 1984.
- Явелов И.С., Грацианский Н.А., Зуйков Ю.А. Вариабельность ритма сердца при острых коронарных синдромах: значение для оценки прогноза заболевания. Обзор. Кардиология. 1997; (2): 61-9.
- Akselrod S., Gordon D., Madwed J.B., Snidman N.C., Shannon D.C., Cohen R.J. Hemodynamic regulation: Investigation by spectral analysis. Am. J. Physiol. 1985; 249: 867-75.
- Kirchhof P., Breithardt G., Bax J., Benninger G., Blomstrom-Lundqvist C., Boriani G. et al., A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Europace. 2016; 18(1): 37-50.
- Wang Z., Page P., Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. Circ. Res. 1992; 71(2): 271-87.
- Jaïs P., Haïssaguerre M., Shah D.C., Chouairi S., Gencel L., Hocini M. et al. A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation. 1997; 95(3): 572-6.
- Task Forse of the European Society of Cardiology and the North American Society of Paciety of Pacing and Electrophysiology. Heart rate variability. Standarts of measurements, physiological interpretation and clinical use. Circulation. 1996; 93: 1043-65.
- Баевский Р.М., Иванов И.И., Чирейкин Л.В. и др. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации). Вестник аритмологии, 2001; (24): 65-87.
- Флейшман А.Н., Филимонов С.Н., Климина Н.В. Новый способ подбора препаратов для лечения артериальной гипертонии на основе спектрального анализа вариабельности ритма сердца. Тер. архив. 2001; (12): 33-9.
- Akselrod S. Components of heart rate variability. Basis studies. In: Heart Rate Variability. Eds M.Malik, A.J.Camm.- Armonk. N.-Y. Futura Pablishity. Comp.Inc. 1995, 147-63.
- Lok N.S., Lau C.P. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation. Pacing Clin.Electrophysiol.1998, 21(2): 386-95.
- Gal P., Elvan A., Rossi P., Schauerte P., Blomström-Lundqvist C., Sciaraffia E. et al. Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics. Int. J. Cardiol. 2016, 205: 83-5.
- Искендеров БГ., Рахматуллов ФК. Структурные и электрофизиологические показатели функции сердца при пароксизмальной мерцательной аритмии. Тер. aрхив. 2001, 12: 52-6.
- Hohendanner F., Heinzel F. R,, Blaschke F., Pieske B. M., Haverkamp1 W., Boldt H. L.,et al. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. Heart Fail Rev. 2018; 23(1): 27-36.
- Patel P.A., Ali N., Hogarth A., Tayebjee M.H. Management strategies for atrial fibrillation. Journal of the Royal Society of Medicine. 2017; 110(1): 13-22.
- Hanley C.M., Robinson V.M., Peter R. Kowey P. R. Status of Antiarrhythmic Drug Development for Atrial Fibrillation. New Drugs and New Molecular Mechanisms. Circ. Arrhythm. Electrophysiol. 2016; 9(3):1-9.
Supplementary files
